BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)

Clinical trial NCT06325332 · COMPLETED

Trial details

NCT number: NCT06325332
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Study type: OBSERVATIONAL

Respiratory Syncytial Virus

Start date: 2024-04-01
Primary completion: 2025-06-30
Enrollment: 49680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.